Loading…
Vivos Therapeutics, Inc. is projected to rise to $0.6082 by 2027, a +41% move from its current price of $0.432. VVOS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.4059 | $0.4321 | $0.4601 | +0.03% |
| Jul 14 | $0.3956 | $0.4322 | $0.4723 | +0.06% |
| Jul 15 | $0.3879 | $0.4324 | $0.482 | +0.08% |
| Jul 16 | $0.3815 | $0.4325 | $0.4903 | +0.11% |
| Jul 17 | $0.376 | $0.4326 | $0.4977 | +0.14% |
| Jul 18 | $0.3711 | $0.4327 | $0.5046 | +0.17% |
| Jul 19 | $0.3667 | $0.4328 | $0.5109 | +0.20% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.3667 | $0.4328 | $0.5109 | +0.20% |
| Week 2 | $0.343 | $0.4337 | $0.5484 | +0.39% |
| Week 3 | $0.326 | $0.4345 | $0.5792 | +0.59% |
| Week 4 | $0.3125 | $0.4354 | $0.6067 | +0.79% |
| Week 5 | $0.3011 | $0.4362 | $0.6322 | +0.98% |
| Week 6 | $0.2912 | $0.4371 | $0.6562 | +1.18% |
| Week 7 | $0.2824 | $0.438 | $0.6793 | +1.38% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.
The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc.
and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
VVOS is the stock symbol for Vivos Therapeutics, Inc. The current price is $0.432 and the market cap is $6M, with a rank of 5220. The stock trades at a micro-cap level within the healthcare space focused on dentofacial therapy and sleep-related treatment modalities.
A major floor 76.9% below — a decisive break under it would weaken the trend.
The nearest floor, 6.9% below — buyers have tended to step in here.
The nearest ceiling, 101.4% above — a clean break opens room to run.
A major ceiling 240.3% above — clearing it would confirm fresh momentum.
Key VVOS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VVOS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.468 | Sell | $0.4594 | Sell |
| MA 10 | $0.4687 | Sell | $0.4705 | Sell |
| MA 20 | $0.4875 | Sell | $0.5059 | Sell |
| MA 50 | $0.6106 | Sell | $0.6546 | Sell |
| MA 100 | $0.9374 | Sell | $0.9678 | Sell |
| MA 200 | $1.64 | Sell | $1.56 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.91 | Neutral |
| Stoch RSI (14) | 67.96 | Neutral |
| CCI (20) | -90.07 | Neutral |
| Williams %R (14) | -68.75 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -7.30 | Sell |
| Bollinger %B (20,2) | 0.24 | Neutral |
| Stochastic %K (14) | 31.25 | Neutral |
| TRIX (15) | -1.46 | Sell |
| Awesome (5,34) | -0.10 | Sell |
| Ultimate (7,14,28) | 42.35 | Neutral |
| Momentum (10) | -0.00 | Sell |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 0.46 | Sell |
| ADX (14) | 23.64 | Sell |
| ATR (14) | 0.03 | Info |
The near-term technical picture shows a NEUTRAL sentiment with RSI(14) at 40. The 50-day simple moving average stands at $0.6106, while the 200-day simple moving average is $1.64. Immediate support is at $0.402 and resistance at $0.87. The 30-day price range spans from $0.2858 to $0.6531, highlighting a narrow recent maneuver within that band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.402 | $0.432 | $0.612 | 0% | Neutral | |
| $0.4413 | $0.6082 | $0.9063 | +41% | Bullish | |
| $0.3792 | $0.5554 | $0.882 | +29% | Bullish | |
| $0.3915 | $0.604 | $1.01 | +40% | Bullish | |
| $0.3454 | $0.5587 | $0.9697 | +29% | Bullish | |
| $0.2671 | $0.4516 | $0.8112 | +5% | Neutral | |
| $0.3044 | $0.5368 | $0.9944 | +24% | Bullish | |
| $0.3625 | $0.6657 | $1.27 | +54% | Bullish | |
| $0.399 | $0.7622 | $1.49 | +76% | Bullish | |
| $0.3899 | $0.7741 | $1.55 | +79% | Bullish | |
| $0.4459 | $0.9909 | $2.18 | +129% | Bullish | |
| $0.6112 | $1.36 | $3.12 | +214% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.402 | $0.432 | $0.4985 | +0.00% |
| August 2026 | $0.3393 | $0.4109 | $0.5183 | -4.89% |
| September 2026 | $0.3608 | $0.4432 | $0.5707 | +7.85% |
| October 2026 | $0.3501 | $0.4354 | $0.5706 | -1.75% |
| November 2026 | $0.3358 | $0.4219 | $0.5609 | -3.10% |
| December 2026 | $0.358 | $0.4543 | $0.612 | +7.67% |
Click any year to see its month-by-month VVOS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, VVOS could reach as high as $0.612, with a base case around $0.432 and support toward $0.402 — roughly 0% from $0.432. A consolidation phase looks the most probable path here.
Expect VVOS to range from $0.4413 to $0.9063 through 2027. The $0.6082 average target implies a +41% move from current prices. That is up +41% on the projected 2026 average. Momentum favours further upside here.
The VVOS price prediction for 2028 points to an average of $0.5554 (low $0.3792, high $0.882) — a potential gain of +29% on today's $0.432. Buyers look set to stay in control over this stretch.
In 2029, VVOS is projected to trade between $0.3915 and $1.01, averaging $0.604 — a potential gain of +40% from today's $0.432. That is up +9% on the projected 2028 average. Momentum favours further upside here.
Vivos Therapeutics, Inc.'s 2030 outlook centres on $0.5587, within a $0.3454 to $0.9697 range. That is -7% versus the projected 2029 average. That marks a +29% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, VVOS could reach as high as $0.8112, with a base case around $0.4516 and support toward $0.2671 — roughly +5% from $0.432. Price action looks broadly range-bound.
Expect VVOS to range from $0.3044 to $0.9944 through 2032. The $0.5368 average target implies a +24% move from current prices. That is up +19% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The VVOS price prediction for 2033 points to an average of $0.6657 (low $0.3625, high $1.27) — a potential gain of +54% on today's $0.432. Momentum favours further upside here.
In 2034, VVOS is projected to trade between $0.399 and $1.49, averaging $0.7622 — a potential gain of +76% from today's $0.432. That is up +14% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Vivos Therapeutics, Inc.'s 2035 outlook centres on $0.7741, within a $0.3899 to $1.55 range. That is up +2% on the projected 2034 average. That marks a +79% change versus current levels. Momentum favours further upside here.
By 2040, VVOS could reach as high as $2.18, with a base case around $0.9909 and support toward $0.4459 — roughly +129% from $0.432. Buyers look set to stay in control over this stretch.
Expect VVOS to range from $0.6112 to $3.12 through 2050. The $1.36 average target implies a +214% move from current prices. That is up +37% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in VVOS today (≈ 2,314.814815 VVOS) could be worth
$3,144.02
+$2,144.02 (+214%) by 2050 · US Dollar
Based on the average projected VVOS price of $1.36 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VVOSwould be worth at today's price.
$1,000 invested in VVOS on Jul 10, 2025 (≈ 149.925036 VVOS) would be worth
$64.77
-$935.23 (-93.5%) today · 0.06× · US Dollar
Based on a VVOS entry price of $6.67 vs. today's $0.432.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.453 | $953.64 | -4.6% |
| 1 month ago | $0.639 | $676.06 | -32.4% |
| 3 months ago | $1.21 | $357.02 | -64.3% |
| 6 months ago | $2.07 | $208.7 | -79.1% |
| 1 year ago | $6.67 | $64.77 | -93.5% |
| All time (5.0y) ago | $112.75 | $3.83 | -99.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VVOS forecast.
Our base-case forecast reaches $0.86 around 2040.
Implied market cap at $0.86: $11.95M
Forecasts indicate a path of price evolution across years, with 2026 showing an average of $0.432 (ROI 0, sentiment NEUTRAL). From 2027 onward, the average price rises to $0.6076 (ROI 40.7%, bullish), then to $0.5548 (ROI 28.4%, bullish) in 2028 and $0.6052 (ROI 40.1%, bullish) in 2029. In 2030, the average is $0.5582 with ROI 29.2% and bullish sentiment, while 2031 shows $0.4505 average (ROI 4.3%, neutral).
The sequence continues with 2032 at $0.5383 (ROI 24.6%), 2033 at $0.6657 (ROI 54.1%), 2034 at $0.7618 (ROI 76.3%), and 2035 at $0.7753 (ROI 79.5%), all bullish. The multi-year horizon shows notable upside with 2040 at $0.9905 average (ROI 129.3%, bullish) and 2050 at $1.36 average (ROI 215.2%, bullish). These figures are estimates and not guarantees.
Tap a question to reveal the answer.
Avg $0.5582, min $0.3451, max $0.9688; ROI 29.2%; sentiment BULLISH.
Forecasts show bullish sentiment in multiple years with positive ROIs (e.g., 2027 ROI 40.7%, 2040 ROI 129.3%, 2050 ROI 215.2%), but some years like 2026 ROI 0% and 2031 ROI 4.3% indicate uncertainty. These are estimates, not guarantees.
Yes. The forecast max values include 2033 $1.27, 2034 $1.49, 2035 $1.55, 2040 $2.17, and 2050 $3.13, indicating potential to exceed $1 in several years.
Market cap $6M; rank 5220.
Vivos Therapeutics, Inc. Community Discussion
0Share your Vivos Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.